All News     |   Press Releases     |   Newsletters     |   Blog

News

Read all of the latest news, press releases, newsletters, and blog posts. Choose a link above to filter by category.

    • 01 JUN 17
    • 0

    LATTICE BIOLOGICS LTD. RECEIVES MULTI-YEAR AMERICAN ASSOCIATION OF TISSUE BANKS RE-ACCREDITATION

    Accreditation Demonstrates Commitment to Highest Standards for Patients and the Medical Community June 1, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company“) is pleased to announce that it has been approved for re-accreditation by the American Association of Tissue Banks (“AATB“) for processing, storage, and distribution of

    Read more →
    • 31 MAY 17
    • 0

    LATTICE BIOLOGICS LTD. APPOINTS CHIEF OPERATING OFFICER

    May 31, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (the “Company“) is pleased to announce the appointment of Darrel Holmes as Chief Operating Officer of the Company, effective May 30, 2017. Mr. Holmes is a seasoned executive with over 30 years of experience in the medical device manufacturing and tissue banking

    Read more →
    • 30 MAY 17
    • 0

    LATTICE BIOLOGICS LTD. REPORTS SECOND QUARTER 2017 HIGHLIGHTS

    Amnion based products grow 76% quarter over quarter May 30, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for the second quarter ended March 31, 2017: Highlights: New sales team focused on high growth markets with immediate impact. Increased gross margins from 19.9%

    Read more →
    • 15 MAY 17
    • 0

    LATTICE BIOLOGICS ANNOUNCES COMPLETION OF PRIVATE PLACEMENT

    May 15, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has closed the previously announced non-brokered private placement of Units (“Private Placement“) in five tranches. As disclosed on April 4, 2017, the Company raised aggregate gross proceeds of approximately US$370,000.

    Read more →
    • 26 APR 17
    • 0

    LATTICE BIOLOGICS ANNOUNCES AGREEMENT TO SUCCESSFULLY REDUCE ROYALTY AND DEBT OBLIGATIONS

    April 26, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF)  (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into an agreement to successfully extinguish approximately US$2.8 million of debt under its royalty purchase agreement (the “Royalty Agreement”) with Grenville Royalty Corp. (“Grenville”), and concurrently restructure the

    Read more →
    • 04 APR 17
    • 0

    LATTICE BIOLOGICS CLOSES FIFTH TRANCHE OF PRIVATE PLACEMENT AND EXTENDS FUNDING RAISE FOR AN ADDITIONAL 30 DAYS

    NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES April 4, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has closed the fifth tranche of its non-brokered private placement of Units of the Company (“Units“) announced on January 19,

    Read more →
    • 20 MAR 17
    • 0

    SERVICE PROVIDER LOYALTY REMAINS STRONG AS LATTICE BIOLOGICS ISSUES SHARES FOR SERVICES AND ANNOUNCES PLANNED DEBT-TO-EQUITY CONVERSION

    NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES March 20, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has obtained TSX Venture Exchange (“TSXV“) approval to issue 75,115 common shares of the Company (“Shares“) to an individual

    Read more →
    • 07 MAR 17
    • 0

    LATTICE BIOLOGICS EXTENDS PRIVATE PLACEMENT

    NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES March 7, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that it is extending its non-brokered private placement of Units of the Company (“Units“), announced on January 19, 2017 (the “Offering“), for an additional

    Read more →

Recent Events